Lol we made assumptions in the lead-up to the FX trial results. Trial success there yet the shareprice barely moved, so it's hard to predict in this market. NEU's Trofinetide becomes an even tastier proposition for Big Pharma with TBI alongside Retts and FX. So we wait.
- Forums
- ASX - By Stock
- NEU
- NEU - Bell Potter Update
NEU - Bell Potter Update, page-14
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B |
Open | High | Low | Value | Volume |
$14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $16.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.57 | 1717 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250 | 16.480 |
1 | 300 | 16.470 |
1 | 500 | 16.400 |
1 | 3 | 16.270 |
1 | 150 | 16.200 |
Price($) | Vol. | No. |
---|---|---|
16.570 | 1717 | 1 |
16.600 | 2001 | 1 |
16.620 | 2306 | 2 |
16.650 | 2000 | 1 |
16.660 | 250 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online